INS and polycystic ovary syndrome: Our findings, in conjunction with the available literature, highlight the potential of using TG/HDL-C as a marker for monitoring IR risk in patients with PCOS from adolescence, especially given that a significant correlation between this ratio and insulin levels was observed at this age (p=0.005, R=0.61).